CB1 receptor drug
Evidence from:
primary |
all sources
Related entities (148)
Mentioned in (47)
Papers in which this entity is mentioned.
- Gene-alcohol interactions in birth defects. (2023)
- Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies. (2021)
- Prenatal drug exposure and neurodevelopmental programming of glucocorticoid signalling. (2020)
- Cannabinoids Exacerbate Alcohol Teratogenesis by a CB1-Hedgehog Interaction. (2019)
- Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences. (2019)
- Sex-dependent effects of in utero cannabinoid exposure on cortical function. (2018)
- The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development. (2018)
- An Update on Non-CB, Non-CB Cannabinoid Related G-Protein-Coupled Receptors. (2017)
- CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function. (2016)
- Dose-dependent teratogenicity of the synthetic cannabinoid CP-55,940 in mice. (2016)
- Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors. (2015)
- CB1-receptor knockout neonatal mice are protected against ethanol-induced impairments of DNMT1, DNMT3A, and DNA methylation. (2015)
- Functional Connectivity Disruption in Neonates with Prenatal Marijuana Exposure. (2015)
- Modulation of pilocarpine-induced seizures by cannabinoid receptor 1. (2014)
- Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. (2014)
- Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity? (2014)
- Ethanol exposure induces neonatal neurodegeneration by enhancing CB1R Exon1 histone H4K8 acetylation and up-regulating CB1R function causing neurobehavioral abnormalities in adult mice. (2014)
- Neuronal substrates and functional consequences of prenatal cannabis exposure. (2014)
- Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential. (2014)
- Moving around the molecule: relationship between chemical structure and in vivo activity of synthetic cannabinoids. (2014)
- Baths salts, spice, and related designer drugs: the science behind the headlines. (2014)
- A survey of synthetic cannabinoid consumption by current cannabis users. (2014)
- Adolescent chronic mild stress alters hippocampal CB1 receptor-mediated excitatory neurotransmission and plasticity. (2013)
- Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. (2013)
- Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors. (2013)
- Synaptic effects induced by alcohol. (2013)
- Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity. (2012)
- Cannabinoid receptor 1 signaling in embryo neurodevelopment. (2012)
- Withdrawal from THC during adolescence: sex differences in locomotor activity and anxiety. (2012)
- Cortical glutamic acid decarboxylase 67 deficiency results in lower cannabinoid 1 receptor messenger RNA expression: implications for schizophrenia. (2012)
- Receptor heteromerization expands the repertoire of cannabinoid signaling in rodent neurons. (2012)
- Cholinergic modulation of synaptic integration and dendritic excitability in the striatum. (2011)
- Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception. (2011)
- AT1R-CB₁R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II. (2011)
- Pharmacological treatment of cannabis dependence. (2011)
- Cannabis and psychosis/schizophrenia: human studies. (2009)
- Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol. (2009)
- Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala. (2009)
- Neuroimaging of children following prenatal drug exposure. (2009)
- Neuroimaging of children following prenatal drug exposure. (2009)
- Interaction between two independent CNR1 variants increases risk for cocaine dependence in European Americans: a replication study in family-based sample and population-based sample. (2009)
- Protein kinases and addiction. (2008)
- The incentive salience of alcohol: translating the effects of genetic variant in CNR1. (2008)
- Acute ethanol suppresses glutamatergic neurotransmission through endocannabinoids in hippocampal neurons. (2008)
- Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. (1997)
- Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain. (1996)
- The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling. (1995)
Merged raw entities (14)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| cb1 receptor | drug | 27 | 89 |
| cb1r | gene | 18 | 56 |
| cb1r | drug | 13 | 51 |
| cannabinoid receptors | drug | 11 | 13 |
| cb1 receptor | gene | 8 | 8 |
| cb1 | drug | 6 | 13 |
| cb1 cannabinoid receptor | drug | 3 | 3 |
| cannabinoid 1 receptor | drug | 2 | 2 |
| cannabinoid receptor 1 | drug | 2 | 2 |
| cannabinoid receptor type 1 | drug | 1 | 1 |
| cb receptor | drug | 1 | 1 |
| cnr1 | drug | 1 | 1 |
| cb1r activation | drug | — | — |
| cb1 receptors | drug | — | — |